Back
Speaker illustration

Doctor Vincenzo Castiglione

Fondazione Toscana Gabriele Monasterio, Pisa (Italy)

I am a cardiologist at Fondazione Toscana Gabriele Monasterio (Pisa) and a PhD student in Translational Medicine at Sant’Anna School of Advanced Studies (Pisa). I graduated in Medicine from the University of Pisa in 2017, and was also an Honour Course student at Sant’Anna School of Advanced Studies, from which I graduated in 2018. My research focuses mainly on heart failure and cardiomyopathies, particularly cardiac amyloidosis.

Presentations

Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysis

Event: ESC Congress 2025

Topic: Infiltrative Myocardial Disease

Session: Treatment of transthyretin amyloidosis

Access
Like
Thumbnail

Plasma transthyretin fractions in transthyretin cardiac amyloidosis patients undergoing tafamidis treatment

Event: ESC Congress 2025

Topic: Infiltrative Myocardial Disease

Session: Shedding light on transthyretin cardiac amyloidosis

Access
Like
Thumbnail

Cardiac remodelling and sympathetic activation in cardiac amyloidosis: insights from transcardiac blood sampling

Event: ESC Congress 2025

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis (2)

Access
Like
Thumbnail

Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysis

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond

Access
Like
Thumbnail

Chest pain after elective percutaneous coronary intervention as trigger of Takotsubo syndrome

Event: ESC Congress 2024

Topic: Clinical

Session: Takotsubo syndrome

Access
Like
Thumbnail

Incidence and clinical characteristics of cardiac amyloidosis in Tuscany and Umbria

Event: ESC Congress 2024

Topic: Infiltrative Myocardial Disease

Session: The different faces of cardiac amyloidosis

Access
Like
Thumbnail

Biohumoral and echocardiographic correlates of tafamidis treatment in transthyretin cardiac amyloidosis

Event: Heart Failure 2023

Topic: Clinical

Session: Novelties in amyloid cardiomyopathy

Access
Like
Thumbnail

Prognostic value of sST2 in heart failure patients with diabetes

Event: Heart Failure 2021

Topic: Biomarkers

Session: ePoster session

Access
Like
Thumbnail

High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis

Event: ESC Congress 2020

Topic: Infiltrative Myocardial Disease

Session: Advances in the Diagnosis and Treatment of Cardiac Amyloidosis

Access
Like
Thumbnail

Biopsy evidence of dual amyloidosis in the same patient: diachronous cardiac involvement by transthyretin and immunoglobulin light chains.

Event: ESC Congress 2020

Topic: Clinical

Session: Amyloidosis

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources